Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Fresenius SE & Co. KGaA    FRE   DE0005785604

FRESENIUS SE & CO. KGAA

(FRE)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Xetra
11/19/2020 11/20/2020 11/23/2020 11/24/2020 11/25/2020 Date
37.64(c) 37.85(c) 37.69(c) 38.03(c) 37.66(c) Last
1 519 292 1 452 700 1 169 715 1 390 401 1 225 697 Volume
-0.95% +0.56% -0.42% +0.90% -0.97% Change
More quotes
Financials
Sales 2020 36 301 M 43 331 M 43 331 M
Net income 2020 1 790 M 2 136 M 2 136 M
Net Debt 2020 24 198 M 28 884 M 28 884 M
P/E ratio 2020 11,8x
Yield 2020 2,12%
Sales 2021 38 061 M 45 432 M 45 432 M
Net income 2021 1 970 M 2 351 M 2 351 M
Net Debt 2021 21 482 M 25 642 M 25 642 M
P/E ratio 2021 10,5x
Yield 2021 2,31%
Capitalization 20 994 M 25 002 M 25 060 M
EV / Sales 2020 1,24x
EV / Sales 2021 1,12x
Nbr of Employees 309 114
Free-Float 72,0%
More Financials
Company
Fresenius SE & Co. KGaA specializes in designing, producing, and selling medical drugs, equipment, and devices used in clinical hospitalization and at home. Net sales break down by activity as follows: - dialysis treatment (49.2%; Fresenius Medical Care): sales of equipment for hemodialysis, pediatric dialysis, peritoneal dialysis, dialysis services, etc.; - hospital administration and engineering (31.4%;... 
More about the company
Notations Surperformance© of Fresenius SE & Co. KGaA
Trading Rating : Investor Rating :
More Ratings
All news about FRESENIUS SE & CO. KGAA
11/24FRESENIUS SE : UBS remains Neutral
MD
11/19FMC FRESENIUS MEDICAL CARE AG & CO K : RBC reiterates its Neutral rating
MD
11/19FMC FRESENIUS MEDICAL CARE AG & CO K : Bernstein reiterates its Neutral rating
MD
11/19FRESENIUS SE : Bernstein reiterates its Buy rating
MD
11/19FRESENIUS SE & CO. KGAA : Preliminary announcement of the publication of quarter..
EQ
11/19FRESENIUS SE & CO. KGAA : Preliminary announcement of the publication of financi..
EQ
11/17FMC FRESENIUS MEDICAL CARE AG & CO K : Jefferies reiterates its Neutral rating
MD
11/13FRESENIUS SE : Receives a Buy rating from Bernstein
MD
11/12FMC FRESENIUS MEDICAL CARE AG & CO K : Gets a Neutral rating from Bernstein
MD
11/09Switzerland's Vifor strikes kidney drug deal with Angion
RE
11/06FRESENIUS SE : Kepler Cheuvreux gives a Buy rating
MD
11/05FMC FRESENIUS MEDICAL CARE AG & CO K : UBS maintains a Buy rating
MD
11/04FMC FRESENIUS MEDICAL CARE AG & CO K : Gets a Buy rating from Goldman Sachs
MD
11/04FRESENIUS SE : From Neutral to Buy by NorldLB
MD
11/03FMC FRESENIUS MEDICAL CARE AG & CO K : Goldman Sachs remains its Buy rating
MD
More news
News in other languages on FRESENIUS SE & CO. KGAA
11/25KRANKENHAUSGESELLSCHAFT : Ausweitung der Beschränkungen notwendig
11/25WOCHENVORSCHAU : Termine bis 09. Dezember 2020
11/25TAGESVORSCHAU : Termine am 26. November 2020
11/24FRESENIUS SE : UBS conserve son opinion neutre
11/24UBS senkt Ziel für Fresenius SE auf 40 Euro - 'Neutral'
More news
Analyst Recommendations on FRESENIUS SE & CO. KGAA
More recommendations
Chart FRESENIUS SE & CO. KGAA
Duration : Period :
Fresenius SE & Co. KGaA Technical Analysis Chart | FRE | DE0005785604 | MarketScreener
Technical analysis trends FRESENIUS SE & CO. KGAA
Short TermMid-TermLong Term
TrendsBullishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Average target price 49,67 €
Last Close Price 37,66 €
Spread / Highest target 80,6%
Spread / Average Target 31,9%
Spread / Lowest Target -53,1%
EPS Revisions
Managers
NameTitle
Stephan Sturm President & Chief Executive Officer
Gerd Krick Chairman-Supervisory Board
Rachel Clare Empey Chief Financial Officer
Niko Stumpfögger Deputy Chairman-Supervisory Board
Klaus-Peter Müller Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
FRESENIUS SE & CO. KGAA-24.95%25 002
AIER EYE HOSPITAL GROUP CO., LTD.103.94%39 788
IHH HEALTHCARE1.65%11 895
BANGKOK DUSIT MEDICAL SERVICES0.00%11 785
RAMSAY HEALTH CARE LIMITED-10.84%10 895
TOPCHOICE MEDICAL CORPORATION98.77%10 395